IR Spectroscopic Imaging Aids Diagnosis of Colon Cancer
By MedImaging International staff writers Posted on 02 Sep 2019 |
Image: A new study asserts that FTIR chemical imaging can help identify colon cancer more accurately (Photo courtesy of ICL).
Fourier-transform infrared (FTIR) spectroscopic imaging can produce 'chemical photographs' of biopsy tissue samples ranging from healthy to cancerous, according to a new study.
Researchers at Imperial College London (Imperial; United Kingdom) and the University of British Columbia (UBC; Vancouver, Canada) undertook FTIR spectroscopic imaging of colon biopsy tissues, combined it with a random forest machine learning (ML) approach in order to classify different stages of colon cancer malignancy. The combination of the optical and ML computational approaches helped eliminate scattering background during the measurements. The results demonstrated that C–H stretching and amide I bands are of little to no significance for the classification of colon malignancy.
The best prediction outcome was found when classification was carried out in the fingerprint region of the mid-infrared spectrum (7-10 micrometers; 1500- 1000 cm−1), which excludes the contribution of amide I and II bands. Overall prediction accuracy was higher than 90%, with dysplastic and hyperplastic tissues well distinguished. The study also showed that computational correction performed better than optical correction, and that disease states can be distinguished effectively even without elimination of scattering effects. The study was published on August 16, 2019, in Analytical and Bioanalytical Chemistry.
“There is urgency in developing new techniques which can identify the early stages of cancer in a way that goes beyond the current histopathology approaches in order to increase survival rates. Coupling spectroscopic imaging with advanced ML approaches aid early detection and understanding of cancer,” said senior author Professor Sergei Kazarian, PhD, of the ICL department of chemical engineering. “There is an excitement of having an enhanced accuracy that promises advances in the early cancer detection and differentiation of disease stages.”
FTIR imaging involves shining an infrared beam at a sample and measuring how much of that light is absorbed at different frequencies, which is used to produce a visual reference of the sample's chemical composition. And although the study was restricted to colon cancer, the researchers have already created models, which have the potential to be applied to other difficult to diagnose cancers such as esophageal cancer, and even non-cancerous anomalies.
Related Links:
Imperial College London
University of British Columbia
Researchers at Imperial College London (Imperial; United Kingdom) and the University of British Columbia (UBC; Vancouver, Canada) undertook FTIR spectroscopic imaging of colon biopsy tissues, combined it with a random forest machine learning (ML) approach in order to classify different stages of colon cancer malignancy. The combination of the optical and ML computational approaches helped eliminate scattering background during the measurements. The results demonstrated that C–H stretching and amide I bands are of little to no significance for the classification of colon malignancy.
The best prediction outcome was found when classification was carried out in the fingerprint region of the mid-infrared spectrum (7-10 micrometers; 1500- 1000 cm−1), which excludes the contribution of amide I and II bands. Overall prediction accuracy was higher than 90%, with dysplastic and hyperplastic tissues well distinguished. The study also showed that computational correction performed better than optical correction, and that disease states can be distinguished effectively even without elimination of scattering effects. The study was published on August 16, 2019, in Analytical and Bioanalytical Chemistry.
“There is urgency in developing new techniques which can identify the early stages of cancer in a way that goes beyond the current histopathology approaches in order to increase survival rates. Coupling spectroscopic imaging with advanced ML approaches aid early detection and understanding of cancer,” said senior author Professor Sergei Kazarian, PhD, of the ICL department of chemical engineering. “There is an excitement of having an enhanced accuracy that promises advances in the early cancer detection and differentiation of disease stages.”
FTIR imaging involves shining an infrared beam at a sample and measuring how much of that light is absorbed at different frequencies, which is used to produce a visual reference of the sample's chemical composition. And although the study was restricted to colon cancer, the researchers have already created models, which have the potential to be applied to other difficult to diagnose cancers such as esophageal cancer, and even non-cancerous anomalies.
Related Links:
Imperial College London
University of British Columbia
Latest General/Advanced Imaging News
- PET Scans Reveal Hidden Inflammation in Multiple Sclerosis Patients
- Artificial Intelligence Evaluates Cardiovascular Risk from CT Scans
- New AI Method Captures Uncertainty in Medical Images
- CT Coronary Angiography Reduces Need for Invasive Tests to Diagnose Coronary Artery Disease
- Novel Blood Test Could Reduce Need for PET Imaging of Patients with Alzheimer’s
- CT-Based Deep Learning Algorithm Accurately Differentiates Benign From Malignant Vertebral Fractures
- Minimally Invasive Procedure Could Help Patients Avoid Thyroid Surgery
- Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery
- AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning
- Imaging Technology Provides Ground-Breaking New Approach for Diagnosing and Treating Bowel Cancer
- CT Coronary Calcium Scoring Predicts Heart Attacks and Strokes
- AI Model Detects 90% of Lymphatic Cancer Cases from PET and CT Images
- Breakthrough Technology Revolutionizes Breast Imaging
- State-Of-The-Art System Enhances Accuracy of Image-Guided Diagnostic and Interventional Procedures
- Catheter-Based Device with New Cardiovascular Imaging Approach Offers Unprecedented View of Dangerous Plaques
- AI Model Draws Maps to Accurately Identify Tumors and Diseases in Medical Images